Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Swayampakula Ramakanth Reiterated (XFOR) at Strong Buy and Held Target at $3 on, Mar 22nd, 2024
Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy and Held Target at $3 on, Mar 22nd, 2024.
Swayampakula has made no other calls on XFOR in the last 4 months.
There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, all agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $1 on, Tuesday, December 12th, 2023
